However, studies have shown a correlation between obesity and NAFLD with the upregulation or downregulation of particular CYP families that could be triggered by inflammatory mediators such as interleukin 1β (IL-1β) and IL-6 (74, 75). The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.